Concepedia

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma

Frede Donskov, Karen Marie Bennedsgaard, Marianne Hokland, Niels Marcussen, Rune Vincents Fisker, H Madsen, Kirsten Fode, Hans von der Maase

Cancer Immunology Immunotherapy · 2004 · 42 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

Robert J. Motzer, Madhu Mazumdar, Jennifer Bacik et al. · Journal of Clinical Oncology · 1999 · 1.8K citations

, , +17

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

G. Fyfe, Richard I. Fisher, S A Rosenberg et al. · Journal of Clinical Oncology · 1995 · 1.4K citations

, , +16

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

Sylvie Négrier, Bernard Escudier, Christine Lasset et al. · New England Journal of Medicine · 1998 · 969 citations · Full text

, , +14

Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer

James Chih‐Hsin Yang, Richard M. Sherry, Seth M. Steinberg et al. · Journal of Clinical Oncology · 2003 · 781 citations · Full text

, , +12

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.

Richard I. Fisher, Steven A. Rosenberg, G. Fyfe · PubMed · 2000 · 441 citations

, , +14